PR Newswire SECAUCUS, N.J., May 13, 2025 SECAUCUS, N.J., May 13, 2025 /PRNewswire/ -- Oncologists feel they are seeing more and more patients with advanced cancers, say screening barriers are the leading reason why, and worry that current ...
PR Newswire SAN JOSE, May 12, 2025 SAN JOSE, May 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Dr. ...
PR Newswire NEW YORK, May 12, 2025 Preclinical Milestones: NEW YORK, May 12, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company developing innovative therapies for unmet medical ...
PR Newswire IRVING, Texas, May 12, 2025 IRVING, Texas, May 12, 2025 /PRNewswire/ -- Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, performs MET Immunohistochemistry (IHC) testing as ...
PR Newswire YANTAI, China, May 12, 2025 YANTAI, China, May 12, 2025 /PRNewswire/ -- On May 12th, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that its phase 3 clinical trial (Study ID: RC48-C016) on ...
PR Newswire LONDON, May 12, 2025 LONDON, May 12, 2025 /PRNewswire/ -- Leucid Bio ("Leucid" or "The Company"), a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies ...
PR Newswire NEW YORK, May 8, 2025 Revolution Medicines receives inaugural Hope Through Science Award at annual gala, Inspiring Hope. NEW YORK, May 8, 2025 /PRNewswire-PRWeb/ -- On Wednesday, April 30, the Lustgarten Foundation presented ...
PR Newswire GENEVA and AMSTERDAM, May 8, 2025 GENEVA and AMSTERDAM, May 8, 2025 /PRNewswire/ -- iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first ...
PR Newswire TORONTO, May 7, 2025 TORONTO, May 7, 2025 /PRNewswire/ - Geneseeq Technology Inc., in collaboration with leading clinical institutions, has developed a cutting-edge blood-based screening test that could transform early detection ...
PR Newswire SAN DIEGO, May 6, 2025 SAN DIEGO, May 6, 2025 /PRNewswire/ -- Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other ...
No increased risk of gynecological cancer in the first years of testosterone use among transmasculine and gender-diverse individuals.
GLP-1 receptor agonists like Ozempic and Wegovy may cut cancer risk beyond controlling blood sugar and weight, offering dual protection.
Researchers find that fat-rich fluid in the abdomen weakens immune defenses in advanced ovarian cancer, revealing new paths for treatment.
Anal cancer rates are rising, especially among older white and Hispanic women, prompting calls for targeted screening.
The RAPID-RT study introduced a heart-sparing technique in radiotherapy for lung cancer, showing improvement in survival by limiting radiation exposure to the heart.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers